DNA and RNA synthetic machinery

The DNA and RNA synthetic machinery is a collective term for the multi-protein complexes and enzymes responsible for the replication of the genome and the transcription of genetic information. This apparatus includes essential components such as DNA polymerases, RNA polymerases, helicases, topoisomerases, and primases, which work in coordination to ensure the high-fidelity synthesis of nucleic acids [1][2]. In clinical practice, this machinery is a primary target for anti-proliferative therapy in oncology and for anti-infective strategies against viruses and bacteria. Therapeutic agents often function as antimetabolites that deplete nucleotide pools or as nucleoside analogs that disrupt polymerization, effectively halting cell division or viral replication [3][4]. However, because these processes are fundamental to the survival of all dividing cells, targeting the human synthetic machinery often results in significant systemic toxicities, particularly in the bone marrow and gastrointestinal tract [5].

Other names

Nucleic acid synthesis machineryDNA/RNA replication and transcription apparatusReplisome and Transcription complex

Drugs targeting the DNA and RNA synthetic machinery operate through several distinct mechanisms: the inhibition of nucleotide precursor synthesis (antimetabolites), competitive inhibition of DNA or RNA polymerases, and the induction of premature chain termination upon incorporation into nascent nucleic acid strands [3][4]. Additionally, certain agents act by stabilizing transient enzyme-DNA complexes, such as those formed by topoisomerases, leading to lethal genomic instability [5].